Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection.
Luke D MahanApril PointsManish R MohankaSrinivas BollineniJohn JoernsVaidehi KazaRicardo M La HozAng GaoSong ZhangFernando TorresAmit BangaPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
A majority of LT patients in the current cohort did not experience an alteration in the trajectory of FVC or FEV1 decline after developing RSV infection, and their post-transplant survival was not adversely impacted. Established CLAD at the time of RSV infection and post infection >10% decline in FVC or FEV1 are independently associated with worse survival after RSV infection.